Joel S. Schuman, MD, FACS Kenneth L. Roper, MD Endowed Chair and Professor of Ophthalmology; Vice Chair for Research Innovation; Co-Director, Glaucoma Service Wills Eye Hospital Email: jss443@drexel.edu

Bio

Dr. Schuman is a pioneer in the field of ophthalmology, lauded for his research, discoveries, inventions, and compassionate patient care over the course of his more than 30-year career. In 2001, he and his colleagues were the first to identify a molecular marker for human glaucoma. In 1991 he was part of the team that invented optical coherence tomography (OCT) technology, which provides quick, non-invasive, high resolution 3D mapping of the eye and has become an essential tool for the detection and treatment of diseases including glaucoma, macular degeneration, and diabetic retinopathy. Today more than 60,000 of these machines are used every day across the globe.

博士

Read more

Credentials

Board Certification

American Board of Ophthalmology

Academic Affiliation

Professor, Ophthalmology, Sidney Kimmel Medical College at Thomas Jefferson University

Education

Fellowship: Harvard Medical School, Massachusetts Eye and Ear Infirmary, Howe Laboratory of Ophthalmology, Glaucoma

Residency: Medical College of Virginia, Virginia Commonwealth University

Medical School: Mount Sinai School of Medicine

Education

• Fellowship, Harvard Medical School, 1989
• MD, Mount Sinai School of Medicine, 1984
• AB in Psychology, Columbia University, 1980

Research Interests

Early detection of disease and its progression, focusing on the invention and investigation of novel diagnostics for eye disease, most specifically for glaucoma.

Publications

To search for journal publications by this doctor, visit the National Library of Medicine